Similar documents
Table 1. Antibacterial spectrum SBT ABPC ABPC CPZ : sulbactamiampicillin : ampicillin : cefoperazone

VOL. 43 NO. 4

CHEMOTHERAPY

Fig.2. Sensitivity distribution of clinical isolates of S. epidermidis (24 strains, 106 CFU/ml) Staphylococcus aureus Staphylococcus epider- midis Ent

Fig. 1 Chemical structure of DL-8280


CHEMOTHERAPY

Key words : 7432-S, Oral cephem, Urinary tract infection Fig. 1. Chemical structure of 7432-S.

Clostridium difficile ciprofloxacin, ofloxacin, norfloxacin Bifidobacterium Lactobacillus Lactobacillus Bacteroides fragilis B. fragilis C. difficile

epidermidis, Enterococcus faecalis, Enterococcus Klebsiella pneumoniae, Proteus mirabilis, indolepositive Proteus spp., Enterobacter spp., Serratia

CHEMOTHERAPY

THE JAPANESE JOURNAL OF ANTIBIOTICS 65 6 Dec DNA 2, , % 1.65% 1.17% 90% 9 Escherichia coli -



Fig. 1 Clinical findings and extent of inflammation area in female urethrocystitis Fig. 2 Classification and distribution of female patients with blad



CHEMOTHERAPY Table 1 Clinical effect of Sultamicillin

VOL.35 S-2 CHEMOTHERAPY Table 1 Sex and age distribution Table 2 Applications of treatment with carumonam Table 3 Concentration of carumonam in human

Table 1. Antibacterial activitiy of grepafloxacin and other antibiotics against clinical isolates


CHEMOTHERAPY JUNE 1993 Table 1. Background of patients in pharmacokinetic study



CHEMOTHERAPY Proteus mirabilis GN-79 Escherichia coli No. 35 Proteus vulgaris GN-76 Pseudomonas aeruginosa No. 11 Escherichia coli ML-1410 RGN-823 Kle

CHEMOTHERAPY JUN Citrobacter freundii 27, Enterobacter aerogenes 26, Enterobacter cloacae 27, Proteus rettgeri 7, Proteus inconstans 20, Proteus



Staphylococcus sp. K.pneumoniae P.mirabilis C.freundii E. cloacae Serratia sp. P. aeruginosa ml, Enterococcus avium >100ƒÊg/ml

Table1MIC of BAY o 9867 against standard strains

CHEMOTHERAPY Table 1 Urinary excretion of mezlocillin Fig. 4 Urinary excretion of mezlocillin Fig. 3 Blood levels of mezlocillin

Title 外傷性脊髄損傷患者の泌尿器科学的研究第 3 報 : 上部尿路のレ線学的研究並びに腎機能について Author(s) 伊藤, 順勉 Citation 泌尿器科紀要 (1965), 11(4): Issue Date URL

04-c-„FŒ{›xŒ¾-4.01

CHEMOTHERAPY FEB Table 1. Activity of cefpirome and others against clinical isolates

Shigella flexneri 2a, Shigella flexneri 3a, Shigella sonnei, Salmonella, Salmonella arizonae, Citorobacter freundii, Enterobacter aerogenes, Enterobac


Fig. 1 Chemical structure of KW-1070

CHEMOTHERAPY JUNE 1986

988 CHEMOTHERAPY NOV. 1971

CHEMOTHERAPY JUNE 1987 Table1 Media used *BHIB, brain heart infusion broth (Difco); /3 -NAD, S -nicotinamidoadeninedinucleotide (Sigma Chemical Co.);

THE JAPANESE JOURNAL OF ANTIBIOTICS 65 6 Dec LVFX 100 mg 3 / mg 2 / LVFX PK PD mg mg 1 1 AUC/MIC



CHEMOTHERAPY FEB Table 1 Background of volunteers

VOL.42 S-1

Visual Evaluation of Polka-dot Patterns Yoojin LEE and Nobuko NARUSE * Granduate School of Bunka Women's University, and * Faculty of Fashion Science,


(ABPC), Carbenicillin (CBPC), Surbenicillin (SBPC), Piperacillin (PIPC), Cephalexin (CEX), Cefaclor (CCL), Cephalothin (CET), Cefazolin (CEZ), Cefotia

CHEMOTHERAPY Fig. 1 Chemical structure of CXM-AX


Study on Application of the cos a Method to Neutron Stress Measurement Toshihiko SASAKI*3 and Yukio HIROSE Department of Materials Science and Enginee


CHEMOTHERAPY MAY. 1988

日本化学療法学会雑誌第61巻第6号

Key words: EHEC, VTEC, verotoxin, Shiga-like toxin

Hisao Takayasu Department of Urology, Faculty of Medicine, University of Tokyo Masaaki Ohkoshi Department of Urology, Tokai University School of Medic

VOL. 34 S-2 CHEMOTH8RAPY 913

The Journal of the Japan Academy of Nursing Administration and Policies Vol 7, No 2, pp 19 _ 30, 2004 Survey on Counseling Services Performed by Nursi


Transcription:

Key words : R-plasmid, Urinary tract infection, E. coli

Fig. 1. MIC distribution against E. coli isolated from urinary tract (366 strains) and isolation - frequencies of drug-resistant strains Table 1. Isolation frequencies of drug-registant Escherichia coli classified by drug resistant patterns * No.of drug-resistant strains in each resistance pattern/no, of drug-resistant strains ** No.of strains in each group/no, of whole strains tested

Table 2. Isolation frequencies of drug-resistant and/or R-plasmid positive strains of Escherichia coli isolated from the year 1982-1985 of drug-resistant strains/no, of isolates tested of R+ strains/no, of drug-resistant strains Table 3. Isolation frequencies of drug-resistant strains and R-plasmid of Escherichia coli classified by the type of infection and resistance patterns from 1982 to 1985 resistant strains strains of R+ strains/no, of drug-resistant strains

Table 4. Relation between drug-resistance patterns of Escherichia coli and isolation frequencies of R-plasmid of R+ strains/no. of resistant strains in each resistance pattern Table 5. Isolation frequencies of drug-resistant strains and R-plasmid of Escherichia coli isolated from uncomplicated urinary tract infection of drug-resistant strains/no, of isolates tested of R+ strains/ no. of drug-resistant strains

Table. 6: Relation between drug-resiirtance patterns and isolation frequencies of R-plasmid in uncomplicated urinary tract infection No.of R+ strains/no.of resistant strains in each resistance patterns Table 7. Relation between drug-resistance patterns and isolation frequencies of R-plasmid in complicated urinary tract infection No.of R-plasmid strains/no.of resistant strains in each resistance patterns Table 8. Isolation frequencies of drug-resistant and/or R-plasmid positive strains of Escherichia coil classified by the type of infection No.of drug-resistant strains/no.of isolates tested No.of R+ strains/no. of drug-resistant strains

Table 9. Relation between indwelling catheter and isolation frequencies of R-plasmid, and drug-resistance patterns No.of drug-resistant strains/no.of isolates tested No.of R+ strains/no.of drug-resistant strains Table 10. Relation between duration of catheterization and isolation frequencies of R-plasmid No.of drug-resistant strains/no.of isolates tested No.of R+ strains/ no.of drug-resistant strains

Percentage of ABPC-resistant strains Fig. 2. Isolation frequency of ABPC-resistant E. coli and R-plasmid from Urological Department of Gifu University by year Table 11. Drug-resistance patterns of ampicillin-resistant Escherichia coli Percentage of ABPC-resistant strains isolated from 1974-1977 Percentage of ABPC-resistant strains isolated from 1982-1985

Table 12. Isolation frequencies of ampicillin-resistant strains and R-plasmid of Escherichia coil by year No.of R+ strains/no.of ABPC-resistant strains

4) HUGHES C, BAUER E, ROBERTS A P: Spread of R plasmid among Escherichia coli causing urinary tract infections. Antimicrob Agents Chemother 20 : 496 `502, 1981 15) DAVIS J, SMITH D I : Plasmid-determined resistance to antimicrobial agents. Ann Rev Microbiol : 469 `518, 1978 20) MITSUHASHI S (ed.) : Bacterial drug resistance R plasmid. Kodansha, 7. Drug Resistance Patterns in Bacteria (MITSUHASHI S), pp.83 ` 90, 1980 21) MITSUHASHI S(ed.) : Transferable drug resistance factor R. University of Tokyo Press, 2. Epidemiology of R Factors (MITSUHASHI S), pp.25 `38, 1971 22) MACRINA F L, KOPECKO D J, JONES K R: A multiple plasmid-containing Escherichia coli strain. Plasmid 417 `420, 1978 25) MITSUHASHI S, HASHIMOTO H, EGAWA R, TANA- KA T, NAGAI Y : Drug resistance of enteric bacteria, IX. Distribution of R factors in gram-negative bacteria from clinical sources. J Bact 93 : 1242 `1245, 1967 26) HARADA K, SUZUKI M, KAMEDA M, MITSUHA- SHI S : On the drug-resistance of enteric bacteria, 2) Transmission of the drug-resistance among Enterobacteriaceae. Jap J Exp Med 30: 289 `299, 1960 27) TANAKA T, NAGAI Y, HASHIMOTO H, MITSU- HASHI S : Distribution of R factors among Shigella strains isolated in Japan. Jap J Microbio 13 : 187 `191, 1969

STUDY ON DRUG RESISTANCE AND R-PLASMID DISTRIBUTION OF E. COLI ISOLATED FROM URINARY TRACT INFECTIONS PANG-KUANG CHANG Department of Urology (Director : Prof. YUKIMICHI KAWADA), Gifu University School of Medicine, 40 Tsukasa-machi, Gifu 500, Japan Drug-resistant strains isolated from urinary tract infections (UTI) have become an increasingly serious problem because of their resistance to chemotherapy and as potential donors of their R-plasmid to sensitive strains. We therefore investigated drug resistance and distribution of R-plasmid isolated from UTI patients. We studied 366 strains of Escherichia coli isolated from clinical specimens in our department from 1982 to 1985. Ampicillin (ABPC), tetracycline (TC), chloramphenicol (CP), streptomycin (SM), kanamycin (KM), sulfanilamide (SA), nalidixic acid (NA), and rifampicin (RFP) were used for the determination of MICs and the selection of transconjugants. Among these 366 strains, ABPC- and SM-resistant strains (41%) were isolated most frequently, followed by those with SA (40%), TC (35%), CP (18%), KM and NA (9%) resistance. No RFPresistant strains were isolated. Multiple drug-resistant strains carried transferable R-plasmid more frequently than single- or double-resistant strains. Among these multiple drug-resistant strains, those isolated from complicated UTI carried transferable R-plasmid more frequently than those from uncomplicated UTI. The catheterized group and catheter-free group had almost the same incidence of drug resistance among the complicated UTI strains, but the catheter-free group carried transferable R-plasmid more frequently than the catheterized group. From the results obtained in this study, we conclude that the incidence of drug-resistant strains and R-plasmid carriers varies according to the type of urinary tract infection.